18 related articles for article (PubMed ID: 9542305)
1. Estimating the risk of parvovirus B19 infection in blood donors and pregnant women in Japan.
Nabae K; Satoh H; Nishiura H; Tanaka-Taya K; Okabe N; Oishi K; Matsumoto K; Hasegawa T
PLoS One; 2014; 9(3):e92519. PubMed ID: 24658180
[TBL] [Abstract][Full Text] [Related]
2. Molecular and serological markers of human parvovirus B19 infection in blood donors: A systematic review and meta-analysis.
Farahmand M; Tavakoli A; Ghorbani S; Monavari SH; Kiani SJ; Minaeian S
Asian J Transfus Sci; 2021; 15(2):212-222. PubMed ID: 34908757
[TBL] [Abstract][Full Text] [Related]
3. Parvovirus B19: What Is the Relevance in Transfusion Medicine?
Juhl D; Hennig H
Front Med (Lausanne); 2018; 5():4. PubMed ID: 29450198
[TBL] [Abstract][Full Text] [Related]
4. Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.
Marano G; Vaglio S; Pupella S; Facco G; Calizzani G; Candura F; Liumbruno GM; Grazzini G
Blood Transfus; 2015 Apr; 13(2):184-96. PubMed ID: 25849894
[No Abstract] [Full Text] [Related]
5. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
Türk Dağı H; Ozdemir M; Baykan M; Baysal B
Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
8. Parvovirus B19 and immune disorders.
Pugliese A; Beltramo T; Torre D; Roccatello D
Cell Biochem Funct; 2007; 25(6):639-41. PubMed ID: 16917962
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of human parvovirus B19 in Taiwan.
Lin KH; You SL; Chen CJ; Wang CF; Yang CS; Yamazaki S
J Med Virol; 1999 Feb; 57(2):169-73. PubMed ID: 9892403
[TBL] [Abstract][Full Text] [Related]
10. [Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia].
Mata Rebón M; Bartolomé Husson C; Bernárdez Hermida I
Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):25-7. PubMed ID: 9542305
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
